Recruitment Challenges for Cannabis Clinical Trials - Emily Lindley, PhD & Rachael Rzasa Lynn, MD @medicinal.genomics
Recruitment Challenges for Cannabis Clinical Trials - Emily Lindley, PhD & Rachael Rzasa Lynn, MD  @medicinal.genomics
Uploaded August 2025 | Updated September 2026, 2 weeks ago
Dr. Emily Lindley is Assistant Professor of Orthopedics and Director of the Colorado Cannabis Research Consortium. Her team’s research aims to identify non-opioid alternatives for the treatment of chronic musculoskeletal pain. One such alternative that has gained increased recognition in recent years is medical cannabis, and her lab is currently studying the health effects of cannabis and cannabinoids for chronic musculoskeletal pain.

Dr. Rachael Rzasa Lynn is a board certified in pain medicine physician and is an Associate Professor in the Department of Anesthesiology at the University of Colorado, where she is the Associate Program Director for the Pain Medicine Fellowship. Her research includes investigations in opioid pharmacology and the use of cannabis for chronic pain.

Rachel and Emily co-authored a poster presented at the most recent ICRS conference titled, Recruitment Challenges in Clinical Studies of Cannabis

During our conversation, we discussed:
* How recruitment for cannabis clinical trials differs from traditional clinical trials
* Why prior experience with cannabis is considered a negative for patient recruitment
* How legal concerns and stigma can deter cannabis-naive patients from enrolling
* Why the participant drop out rate is higher in cannabis trials
* How rescheduling may affect patient recruitment for future trials

Thanks to This Episode's Sponsor: The Society of Cannabis Clinicians

The Society of Cannabis Clinicians’ Med Cann conference offers a rare opportunity for clinicians to dive deep into the clinical realities and therapeutic potential of medical cannabis and psychedelics. Designed with healthcare providers in mind, their sessions focus on case-based learning, emerging protocols, and real-world challenges—offering practical insights that can be immediately applied in your practice.

Learn more at cannabisclinicians.org and use code "CP15" to receive 15% Off Your Registration

Additional Resources
* Recruitment Challenges in Clinical Studies of Cannabis [Poster] - cannmedevents.com/wp-content/uploads/2025/08/P2-21-Recruitment-Challenges-Poster-ICRS-2025.pdf
* Lindley Lab at the University of Colorado - https://medschool.cuanschutz.edu/orthopedics/research/labs/lindley-lab/our-research
Recruitment Challenges for Cannabis Clinical Trials - Emily Lindley, PhD & Rachael Rzasa Lynn, MDPreventing Opioid Overdose with Cannabinoids - Beth Weise, PhDFrequently Identified Nonconformances Applicable to Cannabis Testing - Morgan KeeferThe National  Cannabis Study with Ryan Vandrey, PhD & Johannes Thrul, PhDTissue Culture, Clonal Integrity & Regeneration InnovationCBD increases the effectiveness of Naloxone?What Work Has Been Done With Converting Novel Cannabinoids for Therapeutic Research? Mark ScialdoneHow Would Rescheduling THC to Schedule III Impact Clinical Trials?How cold do you go for butane extraction?Deprescribing Patterns After Medical Cannabis Initiation in Older Adults with PolypharmacyA Look Under the Microscope, Hidden Spores in Cannabis Flowers!White Spots on Your Cannabis Plants? Watch This
Medicinal Genomics |

Recruitment Challenges for Cannabis Clinical Trials - Emily Lindley, PhD & Rachael Rzasa Lynn, MD

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER